Nina Wagner-Johnston, MD, has been appointed Associate Professor of Oncology in the Hematologic Malignancies Division, and will lead the Lymphoma Drug Development Program. At the Siteman Cancer Center at the Washington University in St. Louis, Dr. Wagner-Johnston made several important contributions relevant to the diagnosis and treatment of lymphoma and chronic lymphocytic leukemia. She also brings expertise in neuropathic pain, particularly related to chemotherapy.
Stacy Cooper, MD, has been appointed Instructor in Oncology and Pediatrics. Dr. Cooper’s interests are in improving outcomes for children with hematologic malignancies and the role of transcription factors in leukemogenesis. During her fellowship, Dr. Cooper worked in the laboratory of Alan Friedman, MD, studying novel therapeutic pathways for the treatment of leukemia. Dr. Cooper will manage the Pediatric Hematology/Oncology Fellowship, and she has a strong interest in phase I clinical trials for pediatric oncology and in resident and fellow education.
Catherine Albert, MD, has been appointed Instructor in Oncology and Pediatrics. She will focus on translational research to benefit children with cancer. During Dr. Albert’s fellowship, she focused on molecular pathways in pediatric rhabdomyosarcoma in the laboratory of David Loeb, MD, PhD. She recently received grants from the Stetler Foundation and Bear Necessities Pediatric Cancer Foundation. ■
